North America’s medical devices industry sees a rise of 8% in deal activity in June 2019

15 July 2019 (Last Updated July 15th, 2019 18:11)

North America’s medical devices industry sees a rise of 8% in deal activity in June 2019

North America’s medical devices industry saw a rise of 8% in deal activity during June 2019, when compared with the last 12-month average, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

A total of 81 medical devices industry deals worth $6.49bn were announced for the region in June 2019, against the 12-month average of 75 deals.

Of all the deal types, venture financing saw most activity in June 2019 with 58 transactions, representing a 71.6% share for the region.

In second place was M&A with 19 deals, followed by private equity deals with four transactions, respectively capturing a 23.5% and 4.9% share of the overall deal activity for the month.

In terms of value of deals, M&A was the leading category in North America’s medical devices industry with $5.97bn, while venture financing and private equity deals totalled $515.42m and $3m, respectively.

North America medical devices industry deals in June 2019: Top deals

The top five medical devices deals accounted for 93.8% of the overall value during June 2019.

The combined value of the top five medical devices deals stood at $6.09bn, against the overall value of $6.49bn recorded for the month. The top announced medical devices deal tracked by GlobalData in June 2019 was Dassault Systemes’ $5.8bn acquisition of Medidata Solutions.

In second place was the $100m venture financing of Acutus Medical by 8VC, Advent Venture Partners, Deerfield ManagementLP, GE Ventures, Opaleye Management, Orbimed Advisors, Pura Vida Investments and Xeraya Capital Sdn and in third place was Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners XII, Providence Ventures, Sanofi Ventures, USVP ManagementLlc and Wellington ManagementLLP’s $73m venture financing of Omada Health.

The $60m acquisition of Orthex and Vilex by OrthoPediatrics and InVitae’s acquisition of Singular Bio for $55m held fourth and fifth positions, respectively.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.